Search

Your search keyword '"Brown, David A"' showing total 115 results

Search Constraints

Start Over You searched for: Author "Brown, David A" Remove constraint Author: "Brown, David A" Journal ophthalmology Remove constraint Journal: ophthalmology
115 results on '"Brown, David A"'

Search Results

1. TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2

2. Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials

4. TENAYA and LUCERNE

5. Faricimab Treat-and-Extend for Diabetic Macular Edema

11. Intravitreal Combined Aflibercept + Anti–Platelet-Derived Growth Factor Receptor β for Neovascular Age-Related Macular Degeneration

12. Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration

14. Reply

15. Natural History of Drusenoid Pigment Epithelial Detachment Associated with Age-Related Macular Degeneration

16. Progression of Geographic Atrophy in Age-related Macular Degeneration

17. Retinopathy Regression with Treat and Extend Ranibizumab for Diabetic Macular Edema

18. Plasma Vascular Endothelial Growth Factor Concentrations after Intravitreous Anti–Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema

21. Macular Atrophy in Neovascular Age-Related Macular Degeneration with Monthly versus Treat-and-Extend Ranibizumab

23. Intravitreal Aflibercept for Diabetic Macular Edema: 100-Week Results From the VISTA and VIVID Studies

24. Intravitreal Aflibercept for Diabetic Macular Edema

25. Reply

26. Intravitreal Aflibercept for Macular Edema Following Branch Retinal Vein Occlusion

30. Subretinal Hyperreflective Material in the Comparison of Age-Related Macular Degeneration Treatments Trials

32. Intravitreal Aflibercept for Macular Edema Following Branch Retinal Vein Occlusion

33. Intravitreal Aflibercept for Diabetic Macular Edema

35. Author reply

36. Intravitreal Aflibercept Injection for Neovascular Age-related Macular Degeneration

38. Long-term Outcomes of Ranibizumab Therapy for Diabetic Macular Edema: The 36-Month Results from Two Phase III Trials

41. Aqueous Levels of Fluocinolone Acetonide after Administration of Fluocinolone Acetonide Inserts or Fluocinolone Acetonide Implants

42. Author reply

43. Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration

44. Sustained Delivery Fluocinolone Acetonide Vitreous Inserts Provide Benefit for at Least 3 Years in Patients with Diabetic Macular Edema

45. One-Year Outcomes of the DA VINCI Study of VEGF Trap-Eye in Eyes with Diabetic Macular Edema

46. Vascular Endothelial Growth Factor Trap-Eye for Macular Edema Secondary to Central Retinal Vein Occlusion

47. Ranibizumab for Diabetic Macular Edema

50. Primary Endpoint Results of a Phase II Study of Vascular Endothelial Growth Factor Trap-Eye in Wet Age-related Macular Degeneration

Catalog

Books, media, physical & digital resources